BRC-supported invention to be showcased at major industry fair

A digital health invention supported by NIHR Cambridge BRC is to be showcased at a major industry fair in London.

BloodCounts!, developed by NHS Blood and Transplant’s Dr Nicholas Gleadall and Dr Michael Roberts at the University of Cambridge, will be presented by NIHR Cambridge BRC partner Cambridge Enterprise at the IP4U University Tech Fair on 19-20 September.

It’s the first time that the Technology Transfer Offices (TTOs) of the University of Cambridge, Imperial College London, Oxford University and University College London have held such an event, which will showcase 80 inventions in sustainability and health.

IP4U will be an opportunity for industry to some of the researchers behind the innovations, and find out how they can partner with academics to commercialise their research.

Early warning system

BloodCounts! uses data from routine blood tests and powerful AI-based techniques to scan for abnormal changes in the blood cells of large populations. Based on this information, doctors can then alert public health agencies to potential emerging infectious disease outbreaks,

The development of the algorithms used in BloodCounts! was only possible due to the EpiCov data-sharing initiative pioneered by Cambridge University Hospitals (CUH) and funded by NIHR Cambridge BRC. The EpiCov database contains de-identified patient and NHS staff data from the CUH Electronic Health Record systems, including scan images and laboratory results.

It includes routinely collected information about patients diagnosed with COVID-19 or suspected of having COVID-19, and staff who have been tested for COVID-19. It also includes information about a large number of control patients who do not have a diagnosis of COVID-19.

Prestigious laureate award for Theme Lead Prof Farooqi

Our Nutrition, Obesity, Metabolism and Endocrinology Theme Lead Professor Sadaf Farooqi has been given the prestigious 2024 Outstanding Clinical Investigator award from the Endocrine Society.

The award honours an internationally recognized clinical investigator who has contributed significantly to understanding the pathogenesis and therapy of endocrine and metabolic diseases. It is one of only a handful of Laureate Awards made by the society each year, to celebrate the achievements of the world’s top endocrinologists.

Professor Farooqi researches the fundamental mechanisms that control human energy homeostasis. She discovered the first genes whose disruption causes severe obesity and established that the principal driver of obesity is a failure of the central control of appetite. She also is a keen advocate to raise more awareness around weight stigma and obesity as a disease.

I am delighted and honoured to receive this prestigious award which recognises the dedication and contributions of past and present team members. I would particularly like to thank the many patients and volunteers who have contributed to our clinical research over the years, allowing us to find new ways to diagnose and treat people with severe obesity.

Professor Farooqi

The Endocrine Society is a global community of physicians and scientists, dedicated to accelerating scientific breakthroughs and improving patient health and well-being. Their main annual meeting, now called ENDO, has been held each year since 1916, except for 1943 and 1945 during World War II. Professor Farooqi will be presented with her award at ENDO 2024 in June next year.

Brain’s ‘appetite control centre’ different in people who are overweight or living with obesity

Cambridge scientists, in research supported by the NIHR Cambridge Biomedical Research Centre, have shown that the hypothalamus, a key region of the brain involved in controlling appetite is different in the brains of people who are overweight and people with obesity when compared to people who are a healthy weight.

The researchers say their findings add further evidence to the relevance of brain structure to weight and food consumption.

Current estimations suggest that over 1.9 billion people worldwide are either overweight or obese. In the UK, according to the Office for Health Improvement & Disparities, almost two-thirds of adults are overweight or living with obesity. This increases an individual’s risk of developing a number of health problems, including type 2 diabetes, heart disease and stroke, cancer and poorer mental health.

A large number of factors influence how much we eat and the types of food we eat, including our genetics, hormone regulation, and the environment in which we live. What happens in our brains to tell us that we are hungry or full is not entirely clear, though studies have shown that the hypothalamus, a small region of the brain about the size of an almond, plays an important role.

Dr Stephanie Brown from the Department of Psychiatry and Lucy Cavendish College, University of Cambridge, said: “Although we know the hypothalamus is important for determining how much we eat, we actually have very little direct information about this brain region in living humans. That’s because it is very small and hard to make out on traditional MRI brain scans.”

The majority of evidence for the role of the hypothalamus in appetite regulation comes from animal studies. These show that there are complex interacting pathways within the hypothalamus, with different cell populations acting together to tell us when we are hungry or full.

To get around this, Dr Brown and colleagues used an algorithm developed using machine learning to analyse MRI brain scans taken from 1,351 young adults across a range of BMI scores, looking for differences in the hypothalamus when comparing individuals who are underweight, healthy weight, overweight and living with obesity.

In a study published today in Neuroimage: Clinical, the team found that the overall volume of the hypothalamus was significantly larger in the overweight and obese groups of young adults. In fact, the team found a significant relationship between volume of the hypothalamus and body-mass index (BMI).

These volume differences were most apparent in those sub-regions of the hypothalamus that control appetite through the release of hormones to balance hunger and fullness.

While the precise significance of the finding is unclear – including whether the structural changes are a cause or a consequence of the changes in body weight – one possibility is that the change relates to inflammation. Previous animal studies have shown that a high fat diet can cause inflammation of the hypothalamus, which in turn prompts insulin resistance and obesity. In mice, just three days of a fat-rich diet is enough to cause this inflammation. Other studies have shown that this inflammation can raise the threshold at which animals are full – in other words, they have to eat more food than usual to feel full.

Dr Brown, the study’s first author, added: “If what we see in mice is the case in people, then eating a high-fat diet could trigger inflammation of our appetite control centre. Over time, this would change our ability to tell when we’ve eaten enough and to how our body processes blood sugar, leading us to put on weight.”

Inflammation may explain why the hypothalamus is larger in these individuals, the team say. One suggestion is that the body reacts to inflammation by increasing the size of the brain’s specialist immune cells, known as glia.

Professor Paul Fletcher, the study’s senior author, from the Department of Psychiatry and Clare College, Cambridge, said: “The last two decades have given us important insights about appetite control and how it may be altered in obesity. Metabolic researchers at Cambridge have played a leading role in this.

“Our hope is that by taking this new approach to analysing brain scans in large datasets, we can further extend this work into humans, ultimately relating these subtle structural brain findings to changes in appetite and eating and generating a more comprehensive understanding of obesity.”

The team say more research is needed to confirm whether increased volume in the hypothalamus is a result of being overweight or whether people with larger hypothalami are predisposed to eat more in the first place. It is also possible that these two factors interact with each other causing a feedback loop.

The research was supported by the NIHR Cambridge Biomedical Research Centre, the Bernard Wolfe Health Neuroscience Fund and Wellcome, with additional funding from Alzheimer’s Research UK.

Leading professor of paediatric medicine from Canada to visit as part of our Distinguished Lecturer programme

The NIHR Cambridge BRC is delighted to announce that Professor Catherine Birken, Professor of Paediatric Medicine at the University of Toronto, will visit as part of our Distinguished Lecturer Programme this Thursday 21 September.

Professor Birken will deliver a lecture on obesity prevention trials in early childhood, and how interventions from before conception to infancy and early childhood aim to reduce childhood obesity and optimise early child development, nutrition, and other healthy behaviours.

As well as her research in the promotion of healthy growth, development and well-being in young
children, Professor Birken’s clinical care activities include attending children – including those with complex obesity – at the Hospital for Sick Children (SickKids), affiliated with the University of Toronto. This is Canada’s most research-intensive hospital and the largest centre dedicated to improving children’s health in the country.

The Distinguished Lecturer programme is run by the NIHR Cambridge BRC and features world-leading experts and is open to researchers, clinicians and staff working on the Cambridge Biomedical Campus. There are usually two to three lectures a year.

Professor Birken’s lecture will take place from 4-6.45pm on 21 September at the Jeffrey Cheah Biomedical Centre lecture theatre on the campus, ending with a drinks reception.

Registration is not necessary but helpful for catering purposes. If you would like to attend please email lauren.basham@nhs.net by Monday 11 September.

Cambridge research wins two NIHR regional awards

A research team and senior clinical trial coordinator swooped top awards at the National Institute for Health and Care Research (NIHR) Clinical Research Network (CRN) Eastern celebration awards in July.

The Rheumatology Research Unit at Cambridge University Hospitals were awarded a prize for their commitment to inclusive working, whilst Paula Turnball, senior clinical trial coordinator for the Cambridge Eye Research Centre (CERC) won the ‘Putting People First’ award.

Rheumatology research team

Rheumatology research team receiving award

Their award, inclusive working, recognises people or teams who have been instrumental in developing a new project or implementing new practice to ensure research is delivered with equality, diversity and inclusivity. 

The Rheumatology Research unit study conditions that impact the joints, tendons, muscles, ligaments, and bones, such as arthritis, osteoarthritis and gout. The Cambridge team have been working on studies that explore how different conditions in Rheumatology can affect and respond to treatments in patients from varying ethnic backgrounds. 

The team initiated an inclusion ‘audit’ to identify whether people from different ethnic backgrounds were underrepresented in their research. Using the results of their audit, they are working to open outreach clinics in these areas of need to support inclusive recruitment and increase the diversity of those taking part in their research. Outreach clinics are staffed by small, diverse teams of multilingual staff, ensuring patients feel comfortable with the care provided and safe in the research environment.  

The award judges recognised that the team had ‘gone the extra mile to ensure people from under-served groups can access research opportunities’.  The award was accepted by Jane Rowlands, Lissamma Titti and Katherine Hodges, and was presented by Prof Ruth Endacott, NIHR Director of Nursing and Midwifery.

Sam Wright, lead rheumatology research nurse said: “We are absolutely thrilled to have received this award. Research is for everyone, not only do we want to improve outcomes for patients but to make sure everyone has the opportunity to take part in a study.”

Paula Turnball

Paul Turnbull, senior clinical trial coordinator for the CERC receiving award

Paula works as a senior clinical trial coordinator for the CERC and looks after several different trials in ophthalmology. The team run a variety of trials, anything from questionnaires to surgical and investigational medications.

The award highlighted research teams or individuals who had gone the extra mile for patients and transforming the way research is delivered and to improve the experience for patients.

Paula was nominated by Professor Rupert Bourne, Consultant Ophthalmic Surgeon, who said: “Due largely to her drive, and personable interaction with patients and staff, she has been a big factor behind the growth of the Ophthalmology NIHR portfolio from one study in 2018 to 15 active trials, and five in set-up today. Almost all the patients thank the research team and Paula in particular for being as flexible and thoughtful as possible.”

The award was presented to Paula by Professor Erika Denton, Medical Director and Accountable Officer for CRN East of England at Norfolk and Norwich University Hospitals NHS Foundation Trust.

I was very humbled and proud to win such an award especially as it is patient focused. Our research patients are very important to us. They give up their time, agree to extra tests and procedures and ask for nothing in return. Without them we wouldn’t be able to move medicine forward, so anything we can do to improve their experience is always top priority. I say ‘we’ because the whole team at CERC is exceptional. It really is a privilege to work in research, I feel very lucky.

Paula Turnbull

NIHR employees invited to create LGBTQ+ staff network

As part of Pride Month at NIHR, plans have been announced by the NIHR Research Inclusion team to create an NIHR LGBTQ+ Staff Network that will also be open to all NIHR Infrastructure as well as NIHR coordinating centres.

The acronym LGBTQ+ stands for lesbian, gay, bisexual, trans and queer, with the plus encompassing a number of other identities relating to sexual orientation and gender identity including, but not limited to, asexual, pansexual, non-binary, intersex and genderfluid.

NIHR is starting its inclusive staff network journey with an LGBTQ+ Staff Network in response to the interest we received from colleagues during our 2022 Pride activities. The LGBTQ+ Network will serve as a pilot forerunner to other potential NIHR-wide staff networks focusing on different aspects of diversity and inclusion.

Inclusion is one of the NIHR’s operating principles, and embedding inclusion into our systems, processes and culture is one of the areas of strategic focus highlighted in Best Research for Best Health: The Next Chapter.

LGBTQ+ Network membership

The Network will be open to all staff working as part of NIHR (such as staff in coordinating centres, LCRN core teams, delivery staff in LCRN partner organisations and staff in NIHR infrastructure e.g., ARCs and BRCs) who identify as part of the LGBTQ+ community, as well as any staff who consider themselves friends, family or allies to LGBTQ+ people.

Some staff may already be part of LGBTQ+ groups or networks at their employing organisations – the focus of the NIHR LGBTQ+ Staff Network would be to support members around their roles and functions, rather than in relation to their employer.

What is the purpose of the LGBTQ+ Staff Network?

The NIHR Research Inclusion Team is keen to ensure that those within the Network play an active role in deciding what the Network is for.

The NIHR LGBTQ+ Staff Network may provide a space for peer support, developing mentoring relationships and networking across the NIHR for LGBTQ+ staff. The Network may organise events and activities around inclusion of LGBTQ+ people in the work of the NIHR, such as for key dates such as Pride Month, LGBTQ+ History Month, World AIDS Day, Trans Day of Visibility, etc. It may also contribute to activities that support NIHR’s wider strategic inclusion priorities, to ensure inclusivity around sexuality and gender identity in all aspects of the work of the NIHR.

How do we find out more or get involved?

You can get involved in one of two ways:

  • register your interest in joining a small working group to help us determine the aims and focus of the LGBTQ+ Staff Network and how it will work
  • register your interest in joining the Network once it has been designed.

If you are interested in being part of the Network in either or both of the above capacities, please complete this short form by 14 July 2023 for the NIHR Research Inclusion Team.

Contact:

Please contact the NIHR Research Inclusion Team if you have any further questions or comments.

International Women’s Day 2023 – Sabine Hein

International Women’s Day 2023 – Ana Toribio

3

Celebrating International Women’s Day 2023

Today marks International Women’s Day, celebrated globally on the 8th March it focuses on highlighting women, calling for equal opportunities and removing discrimination.

The NIHR Cambridge BRC is focusing on three women who make substantial contributions to health research. Click on their profiles below to find out more about their roles and why they believe more women are needed in research.​

Cherry May Sanchez

”Research is not your average desk job, and the fulfilment the job brings is far greater. So speak to people working in research, and don’t be afraid to ask to shadow in the area, research is fulfilling, motivating and exciting. Never be afraid to try new things!”

Cherry May Sanchez, Team lead and Cancer Research UK Senior Research Nurse.

“If you’re passionate about learning and discovery, then you have what is needed in research. Listen to your heart to choose the subject that captivates and motivates you, since research will present many challenges. And consciously develop a critical thinking and problem-solving approach.”

Ana Toribio, Stratified Medicine Core Laboratory Next Generation Sequencing (SMCL NGS) Hub Manager

“This day is so important because we need to recognise the hard work that women from all over the world, and from all backgrounds, do and achieve in all aspects of their lives, not just in their career.”

Sabine Hein, Senior Study Coordinator, NIHR BioResource

Three more great events at this year’s Cambridge Festival – and they’re all from BRC researchers

We’ve already publicised our webinar and family event taking place as part of this year’s Cambridge Festival – now we want to let you know about three more events taking place during the Festival, and they’re all from researchers we fund and support.

Check out the details below – and don’t forget to find out about our events (if you haven’t already) and other NIHR events taking place in Cambridge.

Mental Health

The crisis in mental health in young women and girls: does our education system make it worse? What should we do?

Why are girls and young women suffering levels of stress and anxiety so far in excess of those their mothers and grandmothers experienced? What part does stress at school and university play? Do we have too many exams? Is the content of university courses too onerous? Does the method of assessment at UK universities stress out young women? Why are university students more likely to suffer anxiety than their counterparts at work?

Join Professors Sarah-Jayne Blakemore and Tamsin Ford as they examine some potential solutions, in this hour-long talk from 6-7pm on Monday 27 March, taking place at the Babbage Lecture Theatre, Downing Street.

To find out more and book your place.

Imaging

New medical imaging techniques in the era of A.I.

Dr Joshua Kaggie is an MRI physicist and senior research associate in the Department of Radiology, where he works on developing new imaging techniques. Dr Kaggie moved to Cambridge from Utah in 2015 and has been involved in a range of projects including osteoarthritis, cancer, and dementia imaging.

This talk will discuss some of the more novel imaging techniques that are being developed at Addenbrooke’s Hospital, including the use of heavy hydrogen (deuterium) for use as a new cancer imaging method. This talk will discuss artificial intelligence / machine learning (AI/ML) techniques, their current and future impact on medical imaging and diagnostics, and medical imaging research underway at Addenbrooke’s Hospital – with an emphasis on MRI techniques. The talk will feature a live demonstration of interesting AI developments, some of which may not relate to medicine – yet.

The talk is on Monday, 27 March, from 7.30-8.15pm, at University of Cambridge Admissions Office, New Museums site, Bene’t Street. For more information and to book your place.

Neurodegenerative Disease and Dementias

Memory Matters – an in-person discussion about brain health

This event, taking place from 3.30-5.00pm on Thursday 30 March in the Herchel Smith Building, Robinson Way, will be an opportunity to join researchers for a discussion about brain health in the context of ageing and dementia.

Many of us are worried about our memory as we get older, or following stress to the body (such as long COVID), and it is common to wonder whether we might be developing dementia. But, how much do you know about dementia and how it is detected and treated? In this workshop, you will have the chance to meet, and ask questions of, the doctors, psychologists and nurses who run the world-famous Addenbrooke’s Hospital Memory Clinic.

Short presentations will be followed by a live Q&A session with members of the Memory Clinic team.

For more information and details on how to book.

© Copyright - NIHR Cambridge Biomedical Research Centre 2026